IgniteData closed an oversubscribed $11M Series A to expand Archer, its platform for automating clinical trial data movement from EHRs into EDC systems using LLMs. For data and privacy teams, the story is less about “AI in healthcare” and more about reducing manual abstraction while keeping HIPAA exposure contained during model development and validation.
IgniteData closes oversubscribed $11M Series A for clinical trial automation
IgniteData raised an oversubscribed $11 million Series A round on Nov. 5, 2025. The round was led by FCA Venture Partners, with participation from Labcorp Venture Fund and Epsilon.
The company plans to use the funding to expand Archer, its platform designed to automate EHR-to-EDC clinical trial data flows. Archer’s approach includes using large language models (LLMs) to extract structured trial data from unstructured clinical notes, aiming to reduce workload at trial sites and compress trial timelines.
- Data engineering impact: Automating EHR-to-EDC transfer shifts effort from manual abstraction to pipeline governance—schema mapping, exception handling, and auditability become the bottlenecks.
- LLM extraction needs test harnesses: If LLMs are pulling structured fields from free text, teams will need robust evaluation datasets, error taxonomies, and monitoring for drift as note styles and templates change.
- Synthetic notes as a safety valve: Privacy engineers can use synthetic clinical notes to train and validate extraction pipelines while reducing HIPAA exposure during development and QA.
- Market signal from incumbents: Labcorp’s participation suggests established healthcare players are willing to fund workflow automation infrastructure—useful validation for vendors selling into pharma and CRO ecosystems.